DUBLIN, July 28, 2020 /PRNewswire/ -- The "Electrophysiology Market by Product (Lab Devices (3D Mapping, Recording), Ablation Catheters (Cryoablation, RF), Diagnostic Catheters (Conventional, Advanced, Ultrasound)), Indication (AF, AVNRT, WPW), End User (Hospitals, ASCs) - Global Forecasts to 2025" report has been added to ResearchAndMarkets.com's offering.
The global electrophysiology market is projected to reach USD 10.61 billion by 2025 from USD 6.87 billion in 2020, growing at a CAGR of 9.1% from 2020 to 2025.
This report studies the breast biopsy market based on product, indication, end-user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Technological advancements and increasing incidence of target diseases to support market growth
Factors driving the growth of the market are technological advancements; new entrants in the market; growing investments, funds, and grants; and increasing incidence of target diseases and procedures. Emerging markets are also expected to offer high growth opportunities for players operating in this market. However, factors such as high cost of electrophysiology products and inadequate reimbursement, unfavorable healthcare reforms in the US, and the cost-intensive requirement for clinical data for new product launches along with the availability of alternative technologies are expected to restrain the growth of this market in the coming years. The reuse and reprocessing of devices and lack of skilled and experienced electrophysiologists are some of the challenges in this market. The growth of the market is also expected to slow temporarily during the forecast period due to the COVID-19 pandemic.
3D Mapping Systems: The largest segment of EP laboratory devices market
Based on type of product, the EP laboratory devices market is segmented into 3D mapping systems, EP recording systems, RF ablation systems, intra-cardiac echocardiography (ICE) ultrasound imaging systems, EP X-ray systems, and other electrophysiology laboratory devices (MRI systems and EP remote magnetic and robotic navigation systems). 3D mapping systems accounted for the largest share of the global EP laboratory devices market in 2019. Driven by its high growth potential, markets players are increasingly focusing on the launch of new technologically advanced devices. For instance, in August 2018, BioSig Technologies received the US Food and Drug Administration (FDA) clearance for the PURE EP System.
Cryoablation EP Catheters: The largest segment of EP ablation catheters market
The EP ablation catheters market is further segmented into cryoablation EP catheters, radiofrequency ablation catheters, laser ablation systems, and microwave ablation systems. Cryoablation EP catheters accounted for the largest share of the global EP ablation catheters market in 2019. The therapeutic advantages of cryoablation over other ablation modalities such as radiofrequency ablation are driving the growth of this market. In addition, various market players are taking initiatives to increase their market presence and strengthen product portfolio; they are also engaging in clinical studies to evaluate the safety of their products. Such initiatives are further supporting market growth. In May 2019, Koninklijke Philips N.V. (Netherlands) entered into a partnership with Medtronic (Ireland). Philips' KODEX-EPD dielectric imaging and navigation system, dielectric imaging sensors, clinical software and services were expected to be leveraged to support cryoablation procedures performed using the Medtronic Arctic Front Advance cryoablation technology.
Conventional EP Diagnostic Catheters: The largest segment of EP diagnostic catheters market
On the basis of type, the EP diagnostic catheters market is segmented into conventional EP diagnostic catheters, advanced EP diagnostic catheters, and ultrasound EP diagnostic catheters. The conventional EP diagnostic catheters segment accounted for the largest share of the global EP diagnostic catheters market in 2019. This can be attributed to the development of technologically advanced fixed and steerable diagnostic catheters, rising prevalence of cardiac arrhythmias across the globe, and increasing demand for these lower-priced devices in emerging markets.
Atrial Fibrillation: The dominating indication segment of the electrophysiology market
Based on indication, the electrophysiology market is segmented into atrial fibrillation, atrioventricular nodal reentry tachycardia (AVNRT), Wolff-Parkinson-White (WPW) syndrome, atrial flutter, and other indications.
Atrial fibrillation segment commanded the largest share of the electrophysiology market in 2019; this segment is also expected to witness the highest growth during the forecast period. The rapid growth in the aging population across the globe, increasing prevalence of atrial fibrillation, a growing number of ablation procedures related to atrial fibrillation, and the development of advanced electrophysiology products for early diagnosis of atrial fibrillation are expected to drive the growth of this market segment in the coming years.
Hospitals & Cardiac Centers: The largest sub-segment of the electrophysiology segment
Based on end-user, the global electrophysiology market has been segmented into hospitals & cardiac centers and ambulatory surgery centers. The hospitals & cardiac centers segment accounted for the largest share in 2019 due to the increasing ablation procedures, the presence of big cath labs and electrophysiology labs in hospitals, and rising prevalence of CVDs. Technological advancements, coupled with government funding, are also encouraging the installation of new tools and devices in hospitals.
North America: The largest share contributing regional segment of the global electrophysiology market in 2019
The electrophysiology market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. North America accounted for a major share of the electrophysiology market in 2019. Factors such as the high burden of CVDs, an increasing number of clinical trials validating electrophysiology devices, the growing number of approvals for electrophysiology devices, and the presence of key players in this region are driving the growth of the electrophysiology market in the US. Moreover, the growing focus of government organizations on providing funding for research, the rising geriatric population, and the high incidence of cardiac diseases are the major factors driving the electrophysiology market in Canada.
- Technological Advancements
- New Entrants in the Market
- Growing Investments, Funds, and Grants
- Increasing Incidence of Target Diseases and Procedures
- High Cost of Electrophysiology Products and Inadequate Reimbursement
- Unfavorable Healthcare Reforms in the US
- Cost-Intensive Requirement for Clinical Data for New Product Launches along with Availability of Alternative Technologies
- Emerging Markets
- Reuse and Reprocessing of Devices
- Lack of Skilled and Experienced Electrophysiologists
- Abbott Laboratories
- Acutus Medical
- APN Health, LLC
- Baylis Medical
- Boston Scientific Corporation
- Cathrx Ltd.
- Cook Medical
- EP Solutions SA
- GE Healthcare
- Imricor Medical Systems
- Japan Lifeline
- Johnson & Johnson
- Koninklijke Philips N.V.
- Lepu Medical
- Medtronic PLC
- Merit Medical Systems
- Microport Scientific Corporation
- Schwarzer Cardiotek
- TZ Medical
For more information about this report visit https://www.researchandmarkets.com/r/9loxlg
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets